Current Topics in Medicinal Chemistry

Editor-in-Chief

Jia Zhou
Chemical Biology Program
Department of Pharmacology and Toxicology
University of Texas Medical Branch
Galveston, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 6 Issue: 14, July

Editorial [ The Use of Selective Fluorination in Drug Design and Development Guest Editor: Dr. Kenneth L. Kirk ]

Volume:6   Issue: 14
Pp: 1445-1445
Kenneth L. Kirk
DOI: 10.2174/156802606777951118
Published on: 01 March, 2012

Selective Fluorination in Drug Design and Development: An Overview of Biochemical Rationales

Volume:6   Issue: 14
Pp: 1447-1456
Kenneth L. Kirk
DOI: 10.2174/156802606777951073
Published on: 01 March, 2012

Fluorinated Molecules as Drugs and Imaging Agents in the CNS

Volume:6   Issue: 14
Pp: 1457-1464
Shengguo Sun and Adeboye Adejare
DOI: 10.2174/156802606777951046
Published on: 01 March, 2012

Design and Synthesis of Phosphonodifluoromethyl Phenylalanine (F2Pmp):A Useful Phosphotyrosyl Mimetic

Volume:6   Issue: 14
Pp: 1465-1471
Terrence R. Burke
DOI: 10.2174/156802606777951091
Published on: 01 March, 2012

The Strength of Weak Interactions: Aromatic Fluorine in Drug Design

Volume:6   Issue: 14
Pp: 1473-1482
Stephen G. DiMagno and Haoran Sun
DOI: 10.2174/156802606777951127
Published on: 01 March, 2012

Fluorinated Nucleosides as Antiviral and Antitumor Agents

Volume:6   Issue: 14
Pp: 1499-1528
Wei-Dong Meng and Feng-Ling Qing
DOI: 10.2174/156802606777951082
Published on: 01 March, 2012

Fluorinated Natural Products with Clinical Significance

Volume:6   Issue: 14
Pp: 1529-1543
Craig J. Thomas
DOI: 10.2174/156802606777951109
Published on: 01 March, 2012

Peptidyl Fluoro-Ketones as Proteolytic Enzyme Inhibitors

Volume:6   Issue: 14
Pp: 1545-1566
Monica Sani, Roberta Sinisi and Fiorenza Viani
DOI: 10.2174/156802606777951064
Published on: 01 March, 2012